JACQUELINE ROWAN: Open Payments
NPI 1518239581 · NORWICH, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,449 in 106 payments from 16 companies in 2025. Trend: 2023 $2,321 · 2024 $2,325 · 2025 $2,449
Food & beverage: $2,355Education: $95
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 27 | $400 |
| Janssen Biotech, Inc. | 16 | $345 |
| UCB, Inc. | 6 | $255 |
| Amgen Inc. | 10 | $209 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 6 | $200 |
| Arcutis Biotherapeutics, Inc. | 3 | $184 |
| Galderma Laboratories, L.P. | 7 | $179 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 8 | $144 |
| Organon LLC | 5 | $103 |
| Incyte Corporation | 3 | $87 |
Products named: TREMFYA, SKYRIZI, Bimzelx, Otezla, Zoryve, NEMLUVIO, Cabtreo, ILUMYA.
Industry payments across CT — which companies pay providers there.
